Ubs Asset Management Americas Inc Takeda Pharmaceutical CO LTD Transaction History

Ubs Asset Management Americas Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $289,486 - $451,572	-22,234 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $10.3 Million - $12.7 Million	-610,180 Reduced 96.48%	22,234 $438,000
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $785,762 - $875,285	48,654 Added 8.33%	632,414 $10.9 Million
Q2 2019 Aug 15, 2019	SELL	$16.58 - $20.49 $907,373 - $1.12 Million	-54,727 Reduced 8.57%	583,760 $0
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $3.77 Million - $4.85 Million	225,521 Added 54.61%	638,487 $0
Q4 2018 Feb 13, 2019	BUY	$15.64 - $21.1 $6.46 Million - $8.71 Million	412,966 New	412,966 $6.95 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.